haloperidol has been researched along with l 365260 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
| Ibii, N; Ikeda, M; Kihara, T; Matsushita, A | 1 |
| Ashby, CR; Minabe, Y; Wang, RY | 1 |
| Bourin, M; Bradwejn, J; Harro, J; Kõks, S; Lang, A; Männistö, PT; Oreland, L; Soosaar, A; Vasar, E; Volke, V | 1 |
| Corrigall, WA; Higgins, GA; Joharchi, N; Sellers, EM; Wang, Y | 1 |
6 other study(ies) available for haloperidol and l 365260
| Article | Year |
|---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Ceruletide, a CCK-like peptide, attenuates dopamine release from the rat striatum via a central site of action.
Topics: Animals; Benzodiazepinones; Ceruletide; Cholecystokinin; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Haloperidol; Male; Phenylurea Compounds; Potassium; Proglumide; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Cholecystokinin; Vagotomy | 1992 |
The CCK-A receptor antagonist devazepide but not the CCK-B receptor antagonist L-365,260 reverses the effects of chronic clozapine and haloperidol on midbrain dopamine neurons.
Topics: Animals; Benzodiazepinones; Cholecystokinin; Clozapine; Devazepide; Dopamine; Haloperidol; Male; Mesencephalon; Neurons; Phenylurea Compounds; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Reference Values | 1991 |
Role of N-methyl-D-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behaviour in rats.
Topics: Aggression; Animals; Apomorphine; Benzodiazepinones; Brain Chemistry; Clozapine; Devazepide; Dizocilpine Maleate; Haloperidol; Male; Phenylurea Compounds; Radioligand Assay; Rats; Rats, Wistar; Receptors, Cholecystokinin; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate | 1995 |
The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol.
Topics: Animals; Benzodiazepinones; Cholecystokinin; Cocaine; Conditioning, Operant; Cues; Devazepide; Discrimination, Psychological; Dopamine Antagonists; Food; Haloperidol; Heroin; Male; Morphine; Narcotics; Phenylurea Compounds; Rats; Rats, Wistar; Receptors, Cholecystokinin; Self Administration | 1994 |